Wilson AL - Search Results

1

Hypoxia Regulates DPP4 Expression, Proteolytic Inactivation, and Shedding from Ovarian Cancer Cells.

Moffitt LR, Bilandzic M, Wilson AL, Chen Y, Gorrell MD, Oehler MK, Plebanski M, Stephens AN. Moffitt LR, et al. Among authors: wilson al. Int J Mol Sci. 2020 Oct 30;21(21):8110. doi: 10.3390/ijms21218110. Int J Mol Sci. 2020. PMID: 33143089 Free PMC article.

2

New Trends in Anti-Cancer Therapy: Combining Conventional Chemotherapeutics with Novel Immunomodulators.

Wilson AL, Plebanski M, Stephens AN. Wilson AL, et al. Curr Med Chem. 2018;25(36):4758-4784. doi: 10.2174/0929867324666170830094922. Curr Med Chem. 2018. PMID: 28875845 Review.

3

Autoantibodies against HSF1 and CCDC155 as Biomarkers of Early-Stage, High-Grade Serous Ovarian Cancer.

Wilson AL, Moffitt LR, Duffield N, Rainczuk A, Jobling TW, Plebanski M, Stephens AN. Wilson AL, et al. Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):183-192. doi: 10.1158/1055-9965.EPI-17-0752. Epub 2017 Nov 15. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29141850

4

Discovery and Validation of Novel Protein Biomarkers in Ovarian Cancer Patient Urine.

Sandow JJ, Rainczuk A, Infusini G, Makanji M, Bilandzic M, Wilson AL, Fairweather N, Stanton PG, Garama D, Gough D, Jobling TW, Webb AI, Stephens AN. Sandow JJ, et al. Among authors: wilson al. Proteomics Clin Appl. 2018 May;12(3):e1700135. doi: 10.1002/prca.201700135. Epub 2018 Mar 2. Proteomics Clin Appl. 2018. PMID: 29426060

5

Non-Invasive Fluorescent Monitoring of Ovarian Cancer in an Immunocompetent Mouse Model.

Wilson AL, Wilson KL, Bilandzic M, Moffitt LR, Makanji M, Gorrell MD, Oehler MK, Rainczuk A, Stephens AN, Plebanski M. Wilson AL, et al. Among authors: wilson kl. Cancers (Basel). 2018 Dec 31;11(1):32. doi: 10.3390/cancers11010032. Cancers (Basel). 2018. PMID: 30602661 Free PMC article.

6

DPP4 Inhibitor Sitagliptin Enhances Lymphocyte Recruitment and Prolongs Survival in a Syngeneic Ovarian Cancer Mouse Model.

Wilson AL, Moffitt LR, Wilson KL, Bilandzic M, Wright MD, Gorrell MD, Oehler MK, Plebanski M, Stephens AN. Wilson AL, et al. Among authors: wilson kl. Cancers (Basel). 2021 Jan 27;13(3):487. doi: 10.3390/cancers13030487. Cancers (Basel). 2021. PMID: 33513866 Free PMC article.

7

Chemoresistance is mediated by ovarian cancer leader cells in vitro.

Karimnia N, Wilson AL, Green E, Matthews A, Jobling TW, Plebanski M, Bilandzic M, Stephens AN. Karimnia N, et al. Among authors: wilson al. J Exp Clin Cancer Res. 2021 Sep 1;40(1):276. doi: 10.1186/s13046-021-02086-3. J Exp Clin Cancer Res. 2021. PMID: 34470672 Free PMC article.

8

Leader Cells: Invade and Evade-The Frontline of Cancer Progression.

Doran BR, Moffitt LR, Wilson AL, Stephens AN, Bilandzic M. Doran BR, et al. Among authors: wilson al. Int J Mol Sci. 2024 Sep 30;25(19):10554. doi: 10.3390/ijms251910554. Int J Mol Sci. 2024. PMID: 39408880 Free PMC article. Review.

9

Leader cells promote immunosuppression to drive ovarian cancer progression in vivo.

Wilson AL, Moffitt LR, Doran BR, Basri B, Do J, Jobling TW, Plebanski M, Stephens AN, Bilandzic M. Wilson AL, et al. Cell Rep. 2024 Nov 26;43(11):114979. doi: 10.1016/j.celrep.2024.114979. Epub 2024 Nov 13. Cell Rep. 2024. PMID: 39541210 Free article.

10

Challenges in Implementing Comprehensive Precision Medicine Screening for Ovarian Cancer.

Moffitt LR, Karimnia N, Wilson AL, Stephens AN, Ho GY, Bilandzic M. Moffitt LR, et al. Among authors: wilson al. Curr Oncol. 2024 Dec 18;31(12):8023-8038. doi: 10.3390/curroncol31120592. Curr Oncol. 2024. PMID: 39727715 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters